Prognosis
Moderna Ditches 400,000 Vaccine Doses But Still Set to Meet Goal
- The doses, not yet in vials, were part of a 1.4 million batch
- Company says it’s still on track to meet 20-million dose goal
This article is for subscribers only.
Moderna Inc. had to discard 400,000 doses of its experimental Covid-19 shot after a filtration issue compromised the product during the final stages of manufacturing, a U.S. official said Thursday.
Moncef Slaoui, Operation Warp Speed’s chief scientific adviser, disclosed Moderna’s manufacturing hiccup in an interview with Bloomberg News. The 400,000 doses, which weren’t yet placed in vials, were part of a broader 1.4 million batch of its vaccine, Slaoui said.